NCT00105495View on ClinicalTrials.gov

Efficacy Study in Removing Excess Iron From the Heart

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

October 31, 2004

Conditions
Thalassemia MajorHemosiderosis
Interventions
DRUG

Ferriprox (deferiprone)

DRUG

Desferal (deferoxamine)

Trial Locations (4)

10126

Dipartimento di Scienze e Dell' Adolescenza, University of Turin, Turin

11527

1st Department of Pediatrics, Athens University, Aghia Sophia Children's Hospital, Athens

Aghia Sophia Children's Hospital, Athens

09100

Ospedale Regionale Microcitemie, Dipartimento di Scienze, Cagliari

Sponsors

Lead Sponsor

ApoPharma
All Listed Sponsors
lead

ApoPharma

INDUSTRY

NCT00105495 - Efficacy Study in Removing Excess Iron From the Heart | Biotech Hunter | Biotech Hunter